Back

The influence of genetically impaired methylation on the cysteinylglycine and gluthatione concentrations in coronary artery disease patients

1 September 2025 (13:15 - 14:00)
Organised by: Logo
Congress Presentation Part of: Pathophysiology of ischaemic heart disease Pathophysiology and Mechanisms ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Professor Robert Irzmanski

Medical University of Lodz, Lodz (Poland)

7 More presentations in this session

Presentation thumbnail
Unlocking the inflammatory 'code' in multivessel coronary disease: pathological network mediated by the PCSK9-NLRP3 axis and a novel microcirculatory dysfunction prediction model
Professor C. Liu (Tianjin, CN)
Abstract Slides Video
Presentation thumbnail
Adipocytokines and risk of ischaemic events in acute coronary syndromes: an age-dependent relationship
Doctor F. Bruno (Turin, IT)
Abstract Slides Video
Presentation thumbnail
Plasma lysozyme as surrogate biomarker for detection of coronary artery disease in patients without Standard Modifiable Cardiovascular Risk Factors (SMuRFless)
Doctor S. Fathieh (London, GB)
Abstract Slides Video
Presentation thumbnail
Understanding the underpinning of hypertriglyceridemia as a risk factor for atherosclerosis
Doctor M. Ferreira (Funchal, PT)
Abstract Slides Video
Presentation thumbnail
Xanthosine alleviates myocardial ischemia-reperfusion injury through attenuation of cardiomyocyte ferroptosis
Doctor Y. Xu (Nanjing, CN)
Abstract Slides Video

Access the full session

Session thumbnail
Pathophysiology of ischaemic heart disease

The Event

Event poster

ESC Congress 2025

1 September 2025 13:15 CET
You may be interested in
thumbnail
Congress Presentation
Association of genetic mutations and polymorphisms with coronary artery disease
thumbnail
Congress Presentation
Methylome of circulating cell free DNA as a novel biomarker tool: from acute coronary syndrome to broader risk stratification of cardiovascular disease
thumbnail
Congress Presentation
Genetic variability of lipoprotein(a) controls vascular inflammation/redox signalling and predicts adverse cardiovascular outcomes in coronary artery disease

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources